University of the Basque Country Oct 22 2025 An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver cancer. Metabolic fatty liver disease (also known as metabolic hepatic steatosis) is the most common chronic liver disease. It is characterized by an excessive accumulation of fat in the liver in people who do not consume large